Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
30,521,351
-
Share change
-
-1,444,165
-
Total reported value
-
$98,278,247
-
Price per share
-
$3.22
-
Number of holders
-
29
-
Value change
-
-$7,699,687
-
Number of buys
-
12
-
Number of sells
-
16
Institutional Holders of GRACELL BIOTECHNOLOGIES INC - SPONSORED ADS (GRCL) as of Q3 2022
As of 30 Sep 2022,
GRACELL BIOTECHNOLOGIES INC - SPONSORED ADS (GRCL) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,521,351 shares.
The largest 10 holders included
Temasek Holdings (Private) Ltd, ORBIMED ADVISORS LLC, Capital International, Inc./CA/, Frazier Life Sciences Management, L.P., EcoR1 Capital, LLC, FEDERATED HERMES, INC., Vivo Capital, LLC, BlackRock Inc., GREAT POINT PARTNERS LLC, and CAPITAL INTERNATIONAL SARL.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.